$KLDI
KLDiscovery Inc.

2019 Q1 Form 10-Q Financial Statement

#000119312519148095 Filed on May 15, 2019

View on sec.gov

Income Statement

Concept 2019 Q1
Revenue $75.03M
YoY Change
Cost Of Revenue $37.46M
YoY Change
Gross Profit $37.57M
YoY Change
Gross Profit Margin 50.07%
Selling, General & Admin $27.55M
YoY Change
% of Gross Profit 73.32%
Research & Development $1.432M
YoY Change
% of Gross Profit 3.81%
Depreciation & Amortization $12.53M
YoY Change
% of Gross Profit 33.36%
Operating Expenses $38.80M
YoY Change
Operating Profit -$1.233M
YoY Change
Interest Expense $12.07M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$97.00K
YoY Change
Pretax Income -$13.40M
YoY Change
Income Tax $95.00K
% Of Pretax Income
Net Earnings -$13.49M
YoY Change
Net Earnings / Revenue -17.98%
Basic Earnings Per Share -$0.32
Diluted Earnings Per Share -$0.32
COMMON SHARES
Basic Shares Outstanding 42.30M
Diluted Shares Outstanding 42.30M

Balance Sheet

Concept 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M
YoY Change
Cash & Equivalents $4.532M
Short-Term Investments
Other Short-Term Assets $100.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.161M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $230.8M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $230.8M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.161M
Total Long-Term Assets $230.8M
Total Assets $232.0M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K
YoY Change
Accrued Expenses $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $200.4K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $8.100M
YoY Change
Total Long-Term Liabilities $8.100M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $200.4K
Total Long-Term Liabilities $8.100M
Total Liabilities $8.253M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $455.7K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $217.2M
YoY Change
Total Liabilities & Shareholders Equity $232.0M
YoY Change

Cashflow Statement

Concept 2019 Q1
OPERATING ACTIVITIES
Net Income -$13.49M
YoY Change
Depreciation, Depletion And Amortization $12.53M
YoY Change
Cash From Operating Activities -$18.34M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $2.182M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.182M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $225.4M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.593M
YoY Change
NET CHANGE
Cash From Operating Activities -18.34M
Cash From Investing Activities -2.182M
Cash From Financing Activities 1.593M
Net Change In Cash -18.91M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$18.34M
Capital Expenditures $2.182M
Free Cash Flow -$20.52M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Interest Income Other
InterestIncomeOther
792044
CY2019Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
13960
CY2019Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
218714087
CY2019Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
806004
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
578630
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121833
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
456797
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4543641
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24425
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
455670
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6175950
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
216883422
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1127
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6350000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2019Q1 pvt Adjustments To Additional Paid In Capital Common Stock Value Issued Subject To Possible Redemption
AdjustmentsToAdditionalPaidInCapitalCommonStockValueIssuedSubjectToPossibleRedemption
-218714087
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
456797
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
23873
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
231967406
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152342
CY2019Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21810992
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
23873
CY2019Q1 us-gaap Interest Income Other
InterestIncomeOther
792044
CY2019Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
13960
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2932
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
112863
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80512
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
118901
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-259725
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
230000000
CY2018Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230000000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
225400000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6350000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
125000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
335904
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231289096
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1029371
CY2019Q1 pvt Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
456907
CY2018Q4 us-gaap Cash
Cash
19168
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
112863
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
81481
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
969
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
118901
CY2018Q4 pvt Accrued Offering Costs
AccruedOfferingCosts
2500
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
125000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
200382
CY2019Q1 pvt Deferred Underwriting Fee
DeferredUnderwritingFee
8050000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
227374
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-227374
CY2019Q1 us-gaap Liabilities
Liabilities
8253314
CY2019Q1 us-gaap Cash
Cash
1048539
CY2018Q4 us-gaap Liabilities
Liabilities
128469
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
133174
CY2019Q1 us-gaap Assets Current
AssetsCurrent
1161402
CY2018Q4 us-gaap Assets Current
AssetsCurrent
152342
CY2019Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230806004
CY2019Q1 us-gaap Assets
Assets
231967406
CY2018Q4 us-gaap Assets
Assets
152342
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
128469
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2932
CY2019Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-601384
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 pvt Deferred Underwriting Fee
DeferredUnderwritingFee
8050000
CY2019Q1 pvt Deferred Underwriting Fee Rate
DeferredUnderwritingFeeRate
0.035
CY2019Q1 pvt Number Of Warrants Sold
NumberOfWarrantsSold
6350000
CY2019Q1 us-gaap Cash
Cash
1048539
CY2019Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2018-08-02
CY2019Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2019Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21810992
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
Pivotal Acquisition Corp
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001752474
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
PVT
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-144587
CY2018Q4 us-gaap Cash
Cash
19168
CY2019Q1 us-gaap Cash
Cash
1048539
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of estimates </div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 6pt; text-indent: 0.79in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 12pt; text-indent: 0.79in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from the Company&#8217;s estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q1 pvt Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2019Q1 pvt Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
218257180
CY2019Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-601384
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0

Files In Submission

Name View Source Status
0001193125-19-148095-index-headers.html Edgar Link pending
0001193125-19-148095-index.html Edgar Link pending
0001193125-19-148095.txt Edgar Link pending
0001193125-19-148095-xbrl.zip Edgar Link pending
d516220d10q.htm Edgar Link pending
d516220dex311.htm Edgar Link pending
d516220dex312.htm Edgar Link pending
d516220dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pvt-20190331.xml Edgar Link completed
pvt-20190331.xsd Edgar Link pending
pvt-20190331_cal.xml Edgar Link unprocessable
pvt-20190331_def.xml Edgar Link unprocessable
pvt-20190331_lab.xml Edgar Link unprocessable
pvt-20190331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending